-
Trial of Cannabis Derivatives in Treating MS Spasticity to Open in Canada
The MS Society of Canada and CIHR have made a 5-year commitment to a trial to evaluate and guide the use of THC and CBD in treating spasticity and other MS symtoms. Read more about the project here.
What do you think of this news?
Log in to reply.